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a b s t r a c t
Cyclin-dependent kinases (CDKs) have an established role in metazoans and yeast in DNA replication, transcription and cell cycle regulation. Several CDKs and their effectors have been identiﬁed in
the malaria parasite Plasmodium falciparum and their biological functions are beginning to be investigated. Here we report results from the functional characterization of Pfmrk and its effector PfMAT1.
We validated the interactions between Pfmrk and PfMAT1 and pinpointed their intracellular location.
Co-immunoprecipitation studies demonstrated physical interaction between the two proteins and identiﬁed the C-terminal domain of PfMAT1 as the Pfmrk activator domain. Immunoﬂuorescence analyses
using GFP and RFP-tagged versions of Pfmrk and PfMAT1, respectively, demonstrated the co-localization
of these two proteins to the parasite nucleus. Bacterial two-hybrid screen of a P. falciparum cDNA library
using Pfmrk as the bait identiﬁed two plasmodial DNA replication proteins, PfRFC-5 and PfMCM6, as
interactors with Pfmrk. We demonstrate that that these two proteins are substrates of Pfmrk-mediated
phosphorylation and that PfMAT1 confers substrate speciﬁcity to the Pfmrk kinase complex. Collectively,
these data suggest a role for Pfmrk in the nucleus of the parasite presumably in regulation of the DNA
replication machinery.
Published by Elsevier B.V.

1. Introduction
Cyclin-dependent kinases are a large group of highly conserved
proteins that play a critical role in the regulation of various cellular
processes such as cell cycle progression, transcription, DNA replication and repair, apoptosis and differentiation [1]. Active forms
of CDKs are heterodimers comprising of a catalytic Ser/Thr kinase
subunit and a regulatory subunit, usually the cognate cyclin. Binding of a CDK with its cognate cyclin results in the displacement
of a sterically hindering “T-loop” and exposure of residues in the
catalytic cleft resulting in a partially active enzyme. The action
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of CDK activating kinase (CAK) complex then leads to complete
activation of the CDK-cyclin complex via phosphorylation of a conserved Thr residue within the “T-Loop” [2]. In metazoans, CDK7
functions as a CAK which phosphorylates and activates cell cycle
CDKs. The CAK complex, which is also involved in the process
of transcription, consists of CDK7, cyclin H and a third stabilizing partner MAT1 [1]. The MAT1 protein stabilizes and inﬂuences
the substrate speciﬁcity of the CDK7 kinase complex [3]. Sequence
analysis and biochemical data have revealed that the MAT1 protein can be divided into three domains with discrete functions: an
N-terminal RING ﬁnger domain, a central coiled-coil domain and a
hydrophobic C-terminal domain [4]. The C-terminal domain interacts with the CDK7–cyclin H complex and stimulates CDK7 kinase
activity. The central domain is involved in anchoring the CAK to
the TFIIH core, and the N-terminal domain is involved in CTD phosphorylation and transcription activation [4]. The CAK complex has
been shown to be localized in the nucleus and its substrates are
predominantly nuclear [5,6].
Several of these familiar components of the cell cycle regulatory machinery have been identiﬁed and characterized in the
malaria parasite Plasmodium falciparum [7]. The plasmodial life
This document is a U.S. government work and
is not subject to copyright in the United States.
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cycle is characterized by alternation between proliferative and
non-proliferative stages. Sporozoites injected into the bloodstream
by an infected Anopheles mosquito migrate to the liver and invade
hepatocytes, producing up to 40,000 merozoites per hepatocyte.
These merozoites are then released into the bloodstream after
lysis of the infected hepatocyte, and in turn invade erythrocytes,
yielding 20–32 daughter merozoites per erythrocyte, which upon
release go on to invade more erythrocytes [8]. Although the
distinct phases of the malaria cell cycle have not been deﬁned,
it is generally accepted that the invading merozoite is in the G1
stage of the cell cycle. At 18 h post-invasion, the ring stage parasite
progresses to trophozoite stage and DNA synthesis is thought
to be initiated. Several rounds of asynchronous nuclear division
ensue the trophozoite stage [9]. The exact molecular mechanisms
involved in the regulation of this atypical cell cycle are poorly
understood [10], however they are being actively investigated for
identiﬁcation of potential novel drug targets.
Several CDKs, cyclins, and a CDK effector protein have been
identiﬁed in P. falciparum using homology-based PCR and database
mining approaches [10]. Pfmrk shares 46% sequence identity with
human CDK7 and the recombinant protein phosphorylates RNA Pol
II CTD and Histone H1 in vitro in the presence of either human cyclin
H or Pfcyc-1 [11–13]. PfMAT1, a putative homolog of human MAT1,
stimulates the CTD kinase activity of Pfmrk in a cyclin-dependent
manner in vitro [14]. Although it has been demonstrated that plasmodial CDKs are amenable to inhibitory mechanisms exerted by
mammalian CDK inhibitors [15], to date CDK inhibitory proteins
have not been identiﬁed in Plasmodium. Therefore, the regulatory
mechanisms for activating and inhibiting CDK activity in Plasmodium remain to be unraveled. Furthermore, the substrates of CDKs
and how CDKs regulate the malarial cell cycle are not known.
Pfmrk displays highest similarity to mammalian CDK7; however it is unclear if Pfmrk is a functional homologue of CDK7
[13]. In metazoans, CDK7 has a dual function as a CAK and as the
kinase element of the general transcription TFIIH complex which
phosphorylates the CTD of RNA polymerase II. In Saccharomyces
cerevisiae, the CDK7 ortholog Kin28 is a CTD kinase and a member
of the TFIIH complex but does not possess CAK activity. In Schizosaccharomyces pombe, two CAKs have been found—the Mcs6 complex
and the Csk1 [16]. Hence, CDK7 orthologs from various metazoans
seem to have different biological functions. Therefore, Pfmrk may
have a unique role in the cell cycle that may have arisen through
Plasmodium evolution. In fact, phylogenetic analyses suggested that
Pfmrk may not belong to the CDK7 family of CDKs [17,18]. Previous biochemical studies suggested that Pfmrk in association with
Pfcyc-1 or Pfcyc-1-PfMAT1 does not possess CAK activity towards
the CDK1 ortholog PfPK5 [12,14]. Although Pfmrk may function
as a CAK in association with different cyclin subunits or towards
different plasmodial CDKs, initial inquiries were raised as to the biological function of Pfmrk in the absence of a bona ﬁde CAK activity.
The process of DNA replication is initiated by the action of many
enzymes [19]. First, the origin–recognition complex (ORC) is assembled at the replication origin. This is followed by the recruitment of
the pre-replication complex (pre-RC) consisting of Cdc6, Cdt1and
MCM proteins to the ORC. The MCM2–7 proteins form a hexameric complex that assembles at replication origins during early G1
phase [20]. Coordination of the functional interactions between the
MCM2–7 proteins and other components of the pre-RC is mediated by CDKs [19,21]. Subsequently, loading of DNA polymerase
occurs and is mediated by the replication factor complex (RFC)
[22]. The RFC consists of ﬁve members (RFC-1, RFC-2, RFC-3, RFC4 and RFC-5). The loading and activation of the pre-RC occurs at
late G1/early S-phase. Once DNA replication is initiated, the PreRC is disassembled thus preventing the re-replication of DNA until
the cell cycle resets again—in the subsequent G1 phase. Sequential
activation and deactivation of CDKs and other cell cycle regulatory

kinases, ensure that the replication of DNA only occurs once per cell
cycle [23].
Another malarial CDK, PfPK5, has been proposed to play a role in
DNA replication [24,25]. PfPK5 expression and kinase activity levels
peak 36 h post-invasion and PfPK5 was shown to co-localize with
DNA in the early trophozoite stages, i.e., before or at the onset of
DNA synthesis. Two lines of evidence suggest a role for PfPK5 in the
S-phase (a) elevated PfPK5-associated kinase activity was detected
in parasites treated with the DNA synthesis inhibitor aphidicolin
and (b) treatment of parasites with the PfPK5 inhibitors ﬂavopiridol and olomoucine results in decreased DNA replication [26]. Since
no obvious NLSs could be detected in the PfPK5 sequence, the possibility exists that it is co-transported into the nucleus along with
its cognate cyclin (or other effector) where it regulates DNA replication. Nuclear import/export of CDKs and cyclins has been demonstrated to be a mechanism to regulate cell cycle progression [27].
In this study, we describe the functional characterization of the
P. falciparum CDK Pfmrk. We have validated its interactions with
PfMAT1, demonstrated co-localization to the nucleus and identiﬁed
components of the DNA synthesis machinery as substrates of this
enzyme. Taken together, these results suggest a role for Pfmrk in
the DNA replication process.
2. Materials and methods
2.1. Molecular cloning of PfMAT1 deletion mutants
DNA for the construction of PfMAT1 deletion mutants was
ampliﬁed from a plasmid template of PfMAT1 full-length cDNA
in pQE30 [14] with oligonucleotides containing a BamHI restriction site. The full-length and truncated PfMAT1 PCR products were
digested with BamHI (Promega) and cloned into the BamHI site of
pET15b (Novagen). All the constructs were sequenced to check for
orientation and correct reading frame.
2.2. Molecular cloning of MBP-PfMAT1
The MBP-tagged version of PfMAT1 was constructed by amplifying PfMAT1 cDNA with oligonucleotides containing EcoRI and
HindIII restriction sites and cloning the PCR product into pMAL-c2X
vector (New England Biolabs).
2.3. Expression and puriﬁcation of recombinant proteins
Pfmrk (PF10 0141), Pfcyc-1 (PF14 0605), PfMAT1 (PFE0610c),
and RNA Pol II CTD were expressed and puriﬁed from Escherichia
coli as GST tagged (Pfcyc-1 and CTD) or 6 × His tagged (Pfmrk and
PfMAT1) fusion proteins as previously reported [12,14]. PfRFC-5
was expressed in BL21-CodonPlus-RIL E. coli cells, and puriﬁed over
a nickel chelating column under identical conditions previously
described for PfMAT1 [14]. PfRFC-5 puriﬁed as a 40 kDa protein as
determined by SDS-PAGE. GST-tagged PfMCM6 was puriﬁed on a
GSTrap HP column (GE Healthcare) using the same protein puriﬁcation procedures as described for Pfcyc-1. GST-PfMCM6 puriﬁed as
a110 kDa protein as determined by SDS-PAGE. MBP-PfMAT1 protein was puriﬁed on an amylose column (New England Biolabs)
according to the manufacturer’s instructions (www.neb.com).
2.4. Kinase assays
Kinase assays were performed in ﬁlter bottom microtiter plates
as previously described [14]. Brieﬂy, 1.5 g of Pfmrk was assayed
in a 50 l kinase reaction containing kinase buffer (50 mM Tris–HCl
pH 7.5, 2.5 mM MnCl2 , and 1.0 mM DTT) supplemented with 3.0 g
Pfcyc-1 and various concentrations of substrates. The reaction was
started by the addition of an ATP mix containing 12 M ATP (Sigma)
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and 5 Ci (␥-32 P) ATP, 3000 Ci/mmol (Amersham) and activity
assayed at 30 ◦ C for 30 min. Plates were washed on a vacuum manifold (Whatman) with 5% phosphoric acid. Following the wash,
scintillation ﬂuid was added to each well and activity measured in
a Topcount microtiter plate scintillation counter (Packard). Phosphorylation of PfMCM6 was determined using a Kinase-Glo assay
system (Promega) with the same assay conditions as above. Each
assay was performed in triplicate and average kinase activity plotted as relative kinase activity as a percentage above background
(kinase alone without substrate). For autoradiography, kinase reactions as described above were assayed under identical conditions
described, however, following the incubation time, the reaction
was stopped by the addition of 4 × SDS loading buffer and boiled.
The reactions were resolved on a 12% SDS-PAGE, transferred to
nitrocellulose, and exposed to X-ray ﬁlm.
2.5. Pull-down assays
2.5.1. Detection of proteins bound to immobilized GST-Pfcyc-1
10 g of GST-Pfcyc-1 was incubated with 500 L of immobilized
glutathione (Pierce) previously pre-incubated with Wash Buffer
(1:1 of 1 × PBS:ProFound Lysis Buffer from Pierce) at 4 ◦ C on a rotary
shaker for 1 h. The sepharose beads were then washed ﬁve times
with 1 mL Wash Buffer and incubated with 5 g of various proteins
at 4 ◦ C on a rotary shaker for 1 h. Following incubation, the beads
were washed ﬁve times with Wash Buffer and boiled with 2 × SDSPAGE gel loading buffer [28] for 5 min and subjected to SDS-PAGE.
Western Blotting was performed using PVDF membranes (Pierce)
according to the manufacturer’s instructions. Anti-His-HRP (Pierce)
at 1:5000 and anti-MBP-HRP (New England Biolabs) antibodies at
1:25,000 were used to detect Pfmrk and PfMAT1, respectively.
2.6. Detection of proteins bound to immunoprecipitated
MBP-tagged PfMAT1
For co-immunoprecipitation reactions, 5 g of each protein in
the reaction was allowed to incubate on ice for an hour with
frequent mixing. The proteins were then incubated with 500 L
anti-MBP-antibody (New England Biolabs) previously diluted to
1:5000 in Co-IP buffer (50 mM Tris pH 7.5, 250 mM NaCl, 5 mM
EDTA, 0.1% NP-40) at 4 ◦ C on a rotary shaker for 1 h. 100 L of a 50%
slurry of Protein A-agarose (Sigma) resuspended in Co-IP buffer was
added and incubated at 4 ◦ C on a rotary shaker for 1 h. The beads
were then washed ﬁve times with 1 mL Co-IP buffer and boiled
with 2 × SDS-PAGE gel loading buffer for 5 min and subjected to
silver staining (Pierce).
2.7. Creation of GFP-tagged Pfmrk and RFP-tagged PfMAT1
constructs
In order to construct the pCHDR–Pfmrk-GFP (the HPG plasmid),
Pfmrk cDNA [14] was ﬁrst cloned into the pENTR/D-TOPO vector to
create the Pfmrk–pENTR plasmid according to the instructions outlined in the Invitrogen GATEWAY manual (www.invitrogen.com).
Pfmrk–pENTR, the GFP tag in the pDONRP2R-P3 vector, the HSP865 promoter in pDONRP4-P1R, and the pCHDR-3/4 destination
vector [29] were combined in an LR reaction (according to protocols outlined in the GATEWAY manual from Invitrogen). In order to
construct the pHBIL–PfMAT1-RFP (the HMR plasmid), the PfMAT1
cDNA was cloned into the pENTR/D-TOPO vector to create the
PfMAT1–pENTR plasmid. The PfMAT1–pENTR plasmid, the RFP tag
in the pDONRP2R-P3 vector, the HSP86-5 promoter in pDONRP4P1R, and the pHBIL-3/4 destination vector [29] were combined in
another LR reaction. The recombinant plasmids were propagated
in E. coli and extracted by Maxi-prep (QIAGEN) columns for transfection of P. falciparum cultures.
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2.8. Transfection of P. falciparum
Synchronized P. falciparum strain W2 parasites cultured in complete medium at 5% hematocrit and 7% parasitemia (predominantly
rings) were used for transfection. Prior to electroporation, a 5 ml
infected red blood cell (RBC) suspension was centrifuged at 1500 g
at 4 ◦ C and placed on ice. About 100 g of plasmid DNA dissolved in 200 L of 2 × sterile PBS was mixed with the 400 l
of the cell suspension in a pre-chilled 0.2 cm cuvette. Electroporation was performed in a BTX electroporation system at 320 V,
186  resistance and 950 F capacitance. Parasites were ﬁrst transfected with pCHDR–Pfmrk-GFP (HPG) and cultured in 25 mL culture
ﬂasks for 48 h without drug selection. Thereafter, the selection drug
WR992210 was introduced in the culture medium at 2.5 ng/mL.
Drug resistant, GFP-ﬂuorescing parasites appeared in 21–25 days
post-transfection. These Pfmrk-GFP expressing parasites were then
transfected with pHBIL–PfMAT1-RFP (HMR) and selected for BSD
at 2 ng/mL. Drug-resistant parasites were established after 2 weeks
of continuous culture and maintained on dual drug (WR99210 and
BSD) selection for downstream microscopy studies.
2.9. Fluorescence microscopy on Pfmrk-GFP and PfMAT1-RFP
parasites
Infected RBCs were centrifuged and washed twice with 1 × icecold PBS. The pelleted RBCs were then stained with Hoescht 33258
(Invitrogen, 1 mg/mL in ice-cold PBS) for 20 min in the dark on
a low-speed shaker. The RBCs were pelleted once again, washed
twice with ice-cold 1 × PBS, pelleted and placed on to microscope
slides with cover slips. The parasites were visualized for the ﬂuorescence generated by Hoescht, GFP and RFP in an Olympus BX51
ﬂuorescence microscope and the images were captured with a
QImaging RETIGA-2000RV FAST 1394 digital camera using the QImagePro software.
2.10. BacterioMatch two-hybrid screen
The expression of the highly conserved malarial CDKs is toxic
to yeast (Personal Communication, Doug Lacount). Therefore, we
chose to employ a bacterial two-hybrid screen to identify proteins
that interact with Pfmrk rather than the more frequently used yeast
two-hybrid system. A bacterial two-hybrid system (BacterioMatch
II, Stratagene) was used to identify regulatory proteins and substrates of Pfmrk. We constructed a two-hybrid cDNA library from
P. falciparum strain 3D7 cultures consisting of 80% trophozoites
and 20% rings and schizonts. The cDNA library was size fractionated from 400 bp to 3 kb and cloned into the pTRG target vector
according to the manufacturer’s instructions (Statagene). Pfmrk
served as the bait in the screen and was cloned into the EcoRI
and BamHI sites of the pBT vector according to the manufacturer’s
protocol.
After screening for histidine auxotrophy and streptomycin resistance, several positive clones were selected. These clones were
sequenced and a BLAST [30] analysis was performed against the
plasmodial genome database (Plasmodb.org). Results from our
BLAST search yielded several proteins that have been shown to
interact with CDKs in other organisms (Table 1). All two-hybrid
interactions were veriﬁed in at least three independent clones.
From our list of four two-hybrid hits, we selected the already
characterized mini chromosome maintenance protein-6 (PfMCM6)
(PF13 0291) [31] and the replication factor complex subunit ﬁve
(RFC-5) (PF11 0117) for further analyses. Full length PfRFC-5 and
PfMCM6 were subsequently cloned into the pTRG vector via RTPCR and their interactions with Pfmrk were conﬁrmed through a
positive validation two-hybrid screen (Stratagene).

12

D. Jirage et al. / Molecular & Biochemical Parasitology 172 (2010) 9–18

Table 1
List of proteins found to interact with the “Pfmrk bait” in the bacterial two-hybrid system.
PlasmoDB ID

Gene name

Amino acid sequence of the insert

Implicated in biological process

Identiﬁable motifs

PF13 0291

PfMCM6

DNA replication

DNA-dependent ATPase

PF11 0117

PfRFC-5

DNA replication

ATP/GTP binding

PF11 0232

Hypothetical Protein

GALMYADQGICCIDEFDKMDEKDRVAIHEAMEQQTISITKAGIQATLNARASVLAACNPKYGRYDTLKTFAQNVNIPA
SKTPMYRIFVFKDAEFLSEGAQAGLRRTLETYIRNARVILHLEHLSKIIEPLKSRCICIRVPLPSEEEIYSVLQNICKQE
KDNIYACCHIELSTPYLVKAYINVPC

Unknown

Cyclin binding

PF07 0126

Hypothetical Protein

RERAVSCRKQAEKLFNLPEIQPRNRWNQIKVNGTSHIKKAAKLPRCEGIGYDELSQSWVSTFVVHKKF

Transcription

AP2 DNA binding

2.11. Cloning of PfMCM6 and PfRFC-5

3. Results

PfMCM6 was ampliﬁed by polymerase chain reaction from
P. falciparum strain 3D7 cDNA using forward primer 5 GGGAATTCTCAGCTATATTTAATGAAAGTGAATTATC-3 and reverse
primer 5 -GGGAATTCTTAAAAATTGTCAATTTC TTCTTG-3 , digested
with EcoRI and cloned into pGEX-5X-3 (GE Healthcare). This
cloning step incorporated a GST tag at the 5 end of the
PfMCM6 gene. PfRF-C5 was ampliﬁed by polymerase chain reaction from P. falciparum strain 3D7 cDNA using forward primer
5 -GGGGATCCATGTGGCTTGAAAAATATAGC-3 and reverse primer
5 -GGCTGCAGTTATTTTCCATGTAAATTATATTTC-3 . This step facilitated subcloning of PfRFC-5 into the BamHI and PstI sites of the
pQE-30—the 6 × His tagged expression vector (Qiagen).

3.1. The C-terminal hydrophobic domain of PfMAT1 is sufﬁcient
to activate Pfmrk–Pfcyc-1 kinase activity
The PfMAT1 protein sequence displays an overall sequence similarity of 49% to human MAT1 [14]. Human MAT1 contains several
domains responsible for its diverse biological functions; in particular, the C-terminal domain stimulates CDK7 activity [4]. In order
to determine if the analogous domain of PfMAT1 is involved in
activating Pfmrk, we created truncated versions of PfMAT1 and
investigated their ability to activate Pfmrk together with Pfcyc-1 in
an in vitro kinase assays (Fig. 1A). The C-terminal region of PfMAT1
comprising of the hydrophobic domain (amino acids 150–260)

Fig. 1. (A) Schematic drawing of PfMAT1. The ring ﬁnger domain (1–51), the coiled-coil domain (112–150) and hydrophobic domain (150–260) are shown. N- and C-terminal
truncations (PfMAT1/51–150, PfMAT1/150–260, PfMAT1/112–260 and PfMAT1/1–150) are represented. (B) The hydrophobic C-terminus of PfMAT1 stimulates Pfmrk kinase
activity. The ability of PfMAT1 truncated mutants to activate Pfmrk activity was evaluated. Kinase reactions containing 1.5 g of Pfmrk, 3.0 g Pfcyc-1 and 2.0 g CTD were
assayed in the presence of 1.5 g of full-length and various PfMAT1 truncated mutants. Pfmrk kinase activity and the extent of CTD phosphorylation was determined by
microtiter plate scintillation measurements and autoradiography, respectively.
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Fig. 2. (A) PfMAT1 binds to Pfmrk and Pfcyc-1. Various proteins (MBP-tagged PfMAT1, 6 × His-tagged Pfmrk and GST-tagged Pfcyc-1) in the reaction were mixed, immunoprecipitated with anti-MBP antibody bound to protein A-sepharose beads, subjected to SDS-PAGE and silver stained. Arrows identify PfMAT1, Pfcyc-1and Pfmrk. (B) PfMAT1
binds to immobilized Pfcyc-1 in the presence and absence of Pfmrk. PfMAT1 (MBP-tagged) and Pfmrk (6 × His-tagged) were allowed to bind Pfcyc-1 (GST-tagged) bound to
immobilized glutathione beads. Immunoblot analysis was performed with anti-MBP-HRP in order to detect MBP-PfMAT1. (C) Pfmrk binds to Pfcyc-1 only in the absence of
PfMAT1. PfMAT1 (MBP-tagged) and Pfmrk (6 × His-tagged) were allowed to bind Pfcyc-1 (GST-tagged) bound to immobilized glutathione beads. Immunoblot analysis was
performed with anti-His-HRP in order to detect Pfmrk.

was sufﬁcient to stimulate Pfmrk activity 4–5-fold (Fig. 1B). The
segment of PfMAT1 lacking the C-terminal hydrophobic region,
however, failed to stimulate Pfmrk activity (Fig. 1B). Hence, we
conclude that the Pfmrk activation domain lies in its hydrophobic
C-terminus.

(Fig. 2C). The GST tag did not bind Pfmrk or PfMAT1 (data not
shown). These results suggest that Pfmrk, Pfcyc-1 and PfMAT1 can
independently interact with each other; however, we were unable
to detect a trimeric complex presumably due to our experimental
conditions.

3.2. PfMAT1 physically interacts with Pfmrk and Pfcyc-1

3.3. Pfmrk and PfMAT1 co-localize to the nucleus

In order to examine the nature of interactions between PfMAT1,
Pfmrk and Pfcyc-1, pull-down assays were performed as follows.
MBP-PfMAT1 was mixed with Pfmrk in the presence or absence of
Pfcyc-1, and immunoprecipitated with anti-MBP antibody bound to
protein-A-sepharose. The immunoprecipitated proteins were then
visualized with silver staining. PfMAT1 was found to bind independently to both Pfmrk and Pfcyc-1 (Fig. 2A). A control experiment
consisting of the MBP tag alone instead of MBP-PfMAT1 did not
pull down any of the proteins used in the experiment (data not
shown).
To further characterize the interactions between these three
proteins, GST-tagged Pfcyc-1 (or the control GST tag) was bound
to immobilized glutathione and its ability to bind to PfMAT1 and
Pfmrk was examined. PfMAT1 was found to bind to immobilized
Pfcyc-1 in the presence and absence of Pfmrk (Fig. 2B). Pfmrk, however binds to immobilized Pfcyc-1 only in the absence of PfMAT1

In an attempt to understand the cellular function of Pfmrk and
to assess the nature of its interaction with its effector PfMAT1 in
vivo, we constructed Invitrogen’s GATEWAY-based [29] GFP-tagged
version of Pfmrk (HPG) and RFP-tagged version of PfMAT1 (HMR)
under the control of the P. falciparum Hsp86 promotor (Fig. 3A
and B). We resorted to this approach due to the lack of availability of high-quality antibodies to both Pfmrk and PfMAT1. We were
unable to use the antibodies generated against Pfmrk (generated
against the Pfmrk peptide sequence MENNSTERYIFK) and PfMAT1
(generated against the PfMAT1 peptide sequence CYQNERKKIHEIVKEEG) for our immunoﬂuorescence analyses, since these antibodies
failed to identify the corresponding proteins on western blots
from parasite protein extracts (data not shown). Hence, in an
effort to express tagged versions of these proteins, W2 P. falciparum parasites were transfected with the HPG plasmid (Fig. 3A)
and transfectants were selected on medium containing WR99210.
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Fig. 3. GATEWAY-based constructs used to transfect parasites. (A) Hsp86 promoter driven Pfmrk-GFP fusion construct (HPG). (B) Hsp86 promoter driven PfMAT1-RFP
construct (HMR).

Expression of Pfmrk-GFP fusion protein (68 kDa) in the transgenic
parasites was conﬁrmed by immunoblotting using anti-GFP antibodies (Fig. 4A). In order to determine the intracellular location of
Pfmrk-GFP, ﬂuorescence microscopic analyses were performed on
these transgenic parasites. The intracellular ﬂuorescence pattern
of Pfmrk-GFP coincided with nuclear staining observed with the

DNA-staining dye Hoechst 33228 suggesting that Pfmrk is localized in the nucleus (Fig. 4B). Next, W2 parasites expressing the
HPG plasmid were transfected with the HMR plasmid (Fig. 3B) with
the aim of generating parasite cells co-expressing both Pfmrk-GFP
and PfMAT1-RFP. Transgenic parasites harboring both plasmids
were selected on medium containing both WR99210 and BSD.

Fig. 4. Analysis of HPG and HPG; HMR transgenic lines. (A) Western blot depicting the expected 68 kDa Pfmrk-GFP protein in crude HPG extracts. (B) GFP and Hoescht
ﬂuorescence in ring, trophozoite, early schizont and late schizont stages in the HPG-expressing parasites. (C) GFP, RFP and Hoescht ﬂuorescence observed in schizonts of the
HPG and HMR co-expressing parasites.
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Fig. 5. CLUSTAL W alignment of RFC-5 subunits from Drosophila melanogaster (NM 135650.2), Schizosaccharomyces pombe (NP 595646.1) and Plasmodium falciparum
(PF11 0117). Identical amino acids are depicted in bold. The predicted motifs in PfRFC-5 are indicated in color and highlighted. Residues 40–47 (in red) correspond to
the “WalkerA” motif, residues 41–48, 132 and 161 (highlighted) are predicted to fall within the ATP-binding site, residues 128–133 (in purple) correspond to the “WalkerB
motif” and residue 175 (in blue) corresponds to the “Arginine ﬁnger”. The amino acid numbers for PfRFC-5 are indicated to the right. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of the article.)

Microscopic analyses of these double transfectants revealed ﬂuorescence signals in the nucleus predominantly in schizonts (Fig. 4C).
This observation suggests that Pfmrk and PfMAT1 are localized
to the parasite’s nucleus, although the RFP ﬂuorescence is more
extended suggesting that PfMAT1 may not be strictly localized in
the nucleus. Pfmrk and PfMAT1 expressed from a PfCRT (P. falciparum chloroquine resistance transporter) promoter [29] in the
same GATEWAY vectors displayed a similar intracellular expression
pattern (data not shown). The PfCRT promoter is weaker compared
to the PfHsp86 promoter and is considered useful in expressing
transgenes that are toxic to parasites when expressed in higher
levels and does not necessarily result in nuclear localization of
transgenes [29]. Hence, it is not unreasonable to conclude that
the nuclear localization of Pfmrk and PfMAT1 observed in the dual
HPG, HMR lines is a representation of their true native state. Interestingly, we observed the GFP signal for Pfmrk throughout the
different intraerythrocytic developmental stages of the parasites,
however for PfMAT1-RFP, we were only able to observe the RFP
signal in the schizonts. This suggests that PfMAT1 protein stability
might be cell cycle-stage dependent.
3.4. PfRFC-5 and PfMCM6 interact with Pfmrk in the bacterial
two-hybrid system
To date little is known about the in vivo substrates of malarial CDKs. Hence, in order to identify substrates of Pfmrk, we
performed a bacterial two-hybrid screen on a cDNA library prepared from P. falciparum using Pfmrk as the bait. Four proteins
PF13 0291 (PfMCM6), PF11 0117 (PfRFC-5), PF11 0232 (hypothetical protein) and PF07 0126 (hypothetical protein) were found
to interact with Pfmrk (Table 1). Of these, we chose to focus

on PfRFC-5 and PfMCM6 for further investigations. PfRFC-5 displays an overall sequence similarity of 30% to replication factor
complex subunits from Drosophila and yeast (Fig. 5). The RFC
(replication factor complex) is a complex of ﬁve subunits highly
conserved in all eukaryotes. RFC loads the “sliding clamp” PCNA
(proliferating cell nuclear antigen) onto DNA during replication.
The loading of PCNA onto DNA by RFC is an important step
in DNA replication and increases the processivity of DNA polymerase [32]. The RFC subunits share eight regions of high sequence
similarity that include regions involved in protein complex formation, DNA binding, PCNA binding and DNA replication [32]. The
motifs identiﬁed in PfRFC-5 when queried on the NCBI Entrez
website (http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi)
include (i) an ATP-binding site encompassing residues 41–48 and
residues 132 and 161, (ii) the WalkerA motif {consensus sequence
GxxGxGK(S/T)} encompassing residues 40–47, (iii) the WalkerB
motif consensus {contains four aliphatic residues followed by two
negatively-charged residues}, encompassing residues 128–133 and
(iv) an Arginine ﬁnger, residue 175 (Fig. 5). RFC proteins belong to
the AAA+ superfamily of ATPases that contain a P-loop NTPase fold.
The WalkerA domain forms a loop that binds to the alpha and beta
phosphate moieties of the bound nucleotide and the WalkerB motif
is important for interacting with Mg2+ cation. The Arginine ﬁnger is
an AAA+ -family speciﬁc motif that senses ATP binding and hydrolysis and transmits conformational changes [33]. The RFC clamp
loader has been shown to require the Arginine ﬁnger sensors (emanating from each of the subunits) to drive DNA binding and loading
of the PCNA [34].
Another interactor of Pfmrk, PfMCM6 (P. falciparum minichromosome maintenance 6), has been characterized as a member
of a hexameric pre-replication complex (pre-RC). The MCM com-
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Fig. 6. PfMCM6 and PfRFC-5 are substrates of Pfmrk. Kinase assays were performed
with 1.5 g Pfmrk and 3.0 g Pfcyc-1 with various substrates of either 2.0 g CTD,
2.0 g PfRFC-5, 2.0 g PfMCM6 or Histone H1 in the absence or presence of 3.0 g
PfMAT1. Each assay was performed in triplicate and average kinase activity plotted
as relative kinase activity.

plex has been shown to play a key role in the transition of the pre-RC
to the RC and is known to function as a replicative helicase [19].
PfMCM6 was shown to be associated with chromatin at every stage
of the parasite’s intraerythrocytic life stage [31].
3.5. Pfmrk phophorylates PfRFC-5 and PfMCM6 in vitro
Subunits of the RFC and MCM complex are phosphorylated
by CDKs and their phosphorylation status might affect their subcellular localization and their ability to bind DNA and other
subunits [21,35,36]. To determine whether PfRFC-5 and PfMCM6
are substrates of Pfmrk, in vitro phosphorylation assays were performed. Pfmrk was found to phosphorylate both PfRFC-5 and
PfMCM6 in vitro (Fig. 6). Interestingly, Pfmrk-mediated phosphorylation of PfMCM6 was activated by PfMAT1. In the presence of
PfMAT1, Pfmrk kinase activity was stimulated towards the three
substrates—CTD, Histone H1 and PfMCM6. PfRFC-5 seems to be a
good substrate of Pfmrk, however the addition of PfMAT1 did not
stimulate further phosphorylation of PfRFC-5.
4. Discussion
In this study, we have characterized the interactions between
Pfmrk and its effector PfMAT1 in vitro. The data presented from our
co-immunoprecipitation experiments demonstrated stable interactions between PfMAT1 and Pfcyc-1, PfMAT1 and Pfmrk, and
between Pfcyc-1 and Pfmrk. The inability to observe a stable
trimeric complex (Pfmrk–PfMAT1–Pfcyc-1) is most likely due to
our experimental conditions. Co-IP of complexes is sometimes
problematic and may reﬂect stearic hindrance due to the antibodies
or immobilizing supports used in the IP. For example, Rossignol et
al. [37] observed an interaction between CDK7 and cyclin H, CDK7
and MAT1, but were unable to detect an interaction between cyclin
H and MAT1 and Busso et al. [4] demonstrated a weak interaction
between cyclin H and MAT1 even though a CDK7–cyclin H–MAT1
exist as an in vivo trimeric complex. Although a trimeric complex
with Pfmrk was not detected, previous studies demonstrate that
PfMAT1 stimulates Pfmrk kinase activity in a Pfcyc-1 dependent

manner [14], suggesting the formation of a trimeric complex. The
inability to detect the trimeric complex by co-immunoprecipitation
using either puriﬁed recombinant proteins or parasite extracts
(data not shown), may be indicative that future studies to identify the complex may have to utilize afﬁnity chromatography
approaches.
Many characteristics of Pfmrk suggest similarities to CDK7. First,
Pfmrk activity is stimulated by the binding of cyclin H or Pfcyc-1
(a cyclin with the greatest sequence identity to the CDK7 cognate cyclin H) [12] and the association of PfMAT1 [14]. Second,
the CTD of RNA polymerase II is a strong substrate of Pfmrk and
third, Pfmrk displays inhibitor sensitivity proﬁles similar to CDK7
[12,13,38–40]. The present study demonstrates a further similarity
to CDK7 by showing that PfMAT1 interacts with both Pfmrk and
Pfcyc-1. Interaction with both the CDK and cyclin is believed to
stabilize the trimeric complex [41]. The molecular architecture of
PfMAT1 is highly similar to human MAT1 with a ring ﬁnger, coiledcoil and hydrophobic domain. Analogous to the CDK7 complex, our
studies demonstrate that the C-terminal hydrophobic domain of
PfMAT1 is responsible for stimulating Pfmrk activity [4]. The coiledcoil and ring ﬁnger domains of MAT1 are believed to be involved
in protein–protein interactions which may direct the CDK7 complex to speciﬁc substrates [3]. In fact, we observe that PfMAT1
inﬂuences substrate speciﬁcity of Pfmrk. Since the hydrophobic
domain of PfMAT1 activates Pfmrk, it is likely that other PfMAT1
domains may be involved in similar PfMAT1–protein interactions
as observed with mammalian MAT1.
Immunoﬂuorescence analyses show that Pfmrk localizes in the
nucleus along with its effector PfMAT1. This result was surprising
since stretches of basic amino acid sequences representing nuclear
localization signals (NLSs) [42,43] cannot be detected in the amino
acid sequences of Pfmrk. In the case of CDK7, it has been shown that
the KRKR motif is required for nuclear targeting and that mutating
the sequence to NGER retains the protein in the cytoplasm. This
nuclear targeting of CDK7 is necessary to confer the protein with its
CAK activity [44]. It is possible that either the NLS signals of these
malarial CDKs are cryptic or these proteins are chaperoned into
the nucleus by other NLS-containing proteins. Cyclin H is targeted
to the nucleus by a C-terminal NLS (KKRKgyedddyvsKKsKh) [45].
Examination of the amino acid sequences of Pfcyc-1 [12], Pfcyc2, Pfcyc-3 and Pfcyc-4 [46] reveals the presence of putative NLSs
in Pfcyc-1 (KKKKNSKKSKKKKLDNK) and Pfcyc-2 (RSNIYNGNK). An
NLS has not been identiﬁed in the sequences of either hMAT1 or
PfMAT1. Hence, it is tempting for us to speculate that Pfmrk may
be chaperoned into the nucleus by one of its cognate cyclins or other
hitherto unidentiﬁed effector(s).
The identiﬁcation of proteins that interact with Pfmrk provides
evidence for a role in distinct cellular processes. Our studies suggest
that Pfmrk interacts with proteins believed to be involved in gene
expression and DNA replication. One of the hypothetical proteins
identiﬁed, PF07 0126 is a putative transcription factor. It remains to
be investigated if this protein is a transcription factor and whether
Pfmrk plays a role in the regulation of gene expression during the P.
falciparum life cycle. It is not surprising that Pfmrk may have a role
in gene expression as CDK7 and orthologs regulate gene expression
in association with the basal transcription RNA Pol II TFIIH complex
[16,47]. Additionally, we identiﬁed an association of Pfmrk with
regulators of DNA replication, PfRFC-5 and PfMCM6. In mammalian
cells, MAT1 and the CAK complex have been shown to physically
interact with the MCM proteins suggesting a role for CDK7 in DNA
replication [48]. The interaction with the molecular machinery of
DNA replication and transcription is consistent with the nuclear
localization of Pfmrk.
Subunits of the RFC and MCM complex are substrates of CDKs
[23,49]. In this study, we demonstrated that Pfmrk phosphorylates PfRFC-5 and PfMCM6 in vitro. The biological signiﬁcance of
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this phosphorylation is unclear as CDK phosphorylation has been
shown to be involved in both activation and deactivation of the
DNA replication complexes [50]. The malarial cell cycle operates
under the conﬁnes of an endoreduplication process known as
endomitosis wherein S and M phases alternate without intervening
cytokinesis [51,52]. Interestingly, even during endoreduplication
(which occurs during differentiation of mammalian trophoblasts
and megakaryoblasts), CDKs are involved in regulating the endocyclic process. In fact, differences in CDK regulation are responsible
for maintaining either a “normal” mitotic cell cycle versus an endocycle by controlling the assembly and ﬁring of the pre-RC [53].
Many components of the pre-RC and RC are encoded in the plasmodial genome and several have been characterized including
MCMs, ORCs, DNA polymerases and PCNA [31,54–58]. Although
the in vivo phosphorylation status of these DNA replication components remains to be investigated, it is tempting to speculate
that Pfmrk-mediated phosphorylation of PfRFC-5 and PfMCM6 may
regulate the initiation of DNA replication. The microarray data of
Pfmrk, PfMAT1 and Pfcyc-1 suggest high levels of expression from
4 to 28 h peaking at 8 and 24 h—several hours before the start of
DNA replication [59]. PfMCM6 protein has been predominantly
detected in late trophozoites and schizonts, and gene expression
of both PfMCM-6 and PfRFC-5 peaks in late trophozoites through
early schizonts—stages where most DNA replication is thought to
occur [31,60].
In summary, this study shows that Pfmrk physically interacts
with its effector PfMAT1 in vitro and that the C-terminal hydrophobic domain of PfMAT1 is the Pfmrk-activating domain. We have
also shown that Pfmrk and PfMAT1 co-localize in the nucleus and
that regulators of DNA synthesis, PfRFC-5 and PfMCM6, are in vitro
substrates of Pfmrk. Hence, we suggest that Pfmrk may play an
important role in malarial DNA replication. Future studies should
be directed toward characterization of the in vivo Pfmrk-effectorsubstrate complexes in an effort to validate and correlate Pfmrk
kinase activity with cell cycle mediated DNA replication.
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